Methylphenidate and the risk of psychotic disorders and hallucinations in children and adolescents in a large health system

Previous studies have suggested that risk of psychotic events may be increased in children exposed to methylphenidate (MPH). However, this risk has not been fully examined, and the possibility of confounding factors has not been excluded. Patients aged 6-19 years who received at least one MPH prescr...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Man, K. K. C. (VerfasserIn) , Banaschewski, Tobias (VerfasserIn)
Dokumenttyp: Article (Journal)
Sprache:Englisch
Veröffentlicht: 15 November 2016
In: Translational Psychiatry
Year: 2016, Jahrgang: 6, Heft: 11
ISSN:2158-3188
DOI:10.1038/tp.2016.216
Online-Zugang:Verlag, Volltext: https://doi.org/10.1038/tp.2016.216
Verlag, Volltext: https://www.nature.com/articles/tp2016216
Volltext
Verfasserangaben:K.K.C. Man, D. Coghill, E.W. Chan, W.C.Y. Lau, C. Hollis, E. Liddle, T. Banaschewski, S. McCarthy, A. Neubert, K. Sayal, P. Ip and I.C.K. Wong

MARC

LEADER 00000caa a2200000 c 4500
001 1667308491
003 DE-627
005 20220816170603.0
007 cr uuu---uuuuu
008 190612s2016 xx |||||o 00| ||eng c
024 7 |a 10.1038/tp.2016.216  |2 doi 
035 |a (DE-627)1667308491 
035 |a (DE-599)KXP1667308491 
035 |a (OCoLC)1341227754 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 33  |2 sdnb 
100 1 |a Man, K. K. C.  |e VerfasserIn  |0 (DE-588)118835888X  |0 (DE-627)1667308343  |4 aut 
245 1 0 |a Methylphenidate and the risk of psychotic disorders and hallucinations in children and adolescents in a large health system  |c K.K.C. Man, D. Coghill, E.W. Chan, W.C.Y. Lau, C. Hollis, E. Liddle, T. Banaschewski, S. McCarthy, A. Neubert, K. Sayal, P. Ip and I.C.K. Wong 
264 1 |c 15 November 2016 
300 |a 7 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Gesehen am 12.06.2019 
520 |a Previous studies have suggested that risk of psychotic events may be increased in children exposed to methylphenidate (MPH). However, this risk has not been fully examined, and the possibility of confounding factors has not been excluded. Patients aged 6-19 years who received at least one MPH prescription were identified using Hong Kong population-based electronic medical records on the Clinical Data Analysis and Reporting System (2001-2014). Using the self-controlled case series design, relative incidence of psychotic events was calculated comparing periods when patients were exposed to MPH with non-exposed periods. Of 20,586 patients prescribed MPH, 103 had an incident psychotic event; 72 (69.9%) were male and 31 (30.1%) female. The mean age at commencement of observation was 6.95 years and the mean follow-up per participant was 10.16 years. On average, each participant was exposed to MPH for 2.17 years. The overall incidence of psychotic events during the MPH exposure period was 6.14 per 10,000 patient-years. No increased risk was found during MPH-exposed compared with non-exposed periods (incidence rate ratio (IRR) 1.02 (0.53-1.97)). However, an increased risk was found during the pre-exposure period (IRR 4.64 (2.17-9.92)). Results were consistent across all sensitivity analyses. This study does not support the hypothesis that MPH increases risk of incident psychotic events. It does indicate an increased risk of psychotic events before the first prescription of MPH, which may be because of an association between psychotic events and the behavioural and attentional symptoms that led to psychiatric assessment and initiation of MPH treatment. 
700 1 |a Banaschewski, Tobias  |d 1961-  |e VerfasserIn  |0 (DE-588)115856110  |0 (DE-627)507227301  |0 (DE-576)178364703  |4 aut 
773 0 8 |i Enthalten in  |t Translational Psychiatry  |d London : Nature Publishing Group, 2011  |g 6(2016,11) Artikel-Nummer e956, 7 Seiten  |h Online-Ressource  |w (DE-627)660807378  |w (DE-600)2609311-X  |w (DE-576)345003462  |x 2158-3188  |7 nnas  |a Methylphenidate and the risk of psychotic disorders and hallucinations in children and adolescents in a large health system 
773 1 8 |g volume:6  |g year:2016  |g number:11  |g extent:7  |a Methylphenidate and the risk of psychotic disorders and hallucinations in children and adolescents in a large health system 
856 4 0 |u https://doi.org/10.1038/tp.2016.216  |x Verlag  |x Resolving-System  |3 Volltext 
856 4 0 |u https://www.nature.com/articles/tp2016216  |x Verlag  |3 Volltext 
951 |a AR 
992 |a 20190612 
993 |a Article 
994 |a 2016 
998 |g 115856110  |a Banaschewski, Tobias  |m 115856110:Banaschewski, Tobias  |d 60000  |e 60000PB115856110  |k 0/60000/  |p 7 
999 |a KXP-PPN1667308491  |e 3486259504 
BIB |a Y 
SER |a journal 
JSO |a {"title":[{"title_sort":"Methylphenidate and the risk of psychotic disorders and hallucinations in children and adolescents in a large health system","title":"Methylphenidate and the risk of psychotic disorders and hallucinations in children and adolescents in a large health system"}],"name":{"displayForm":["K.K.C. Man, D. Coghill, E.W. Chan, W.C.Y. Lau, C. Hollis, E. Liddle, T. Banaschewski, S. McCarthy, A. Neubert, K. Sayal, P. Ip and I.C.K. Wong"]},"type":{"media":"Online-Ressource","bibl":"article-journal"},"physDesc":[{"extent":"7 S."}],"recId":"1667308491","language":["eng"],"note":["Gesehen am 12.06.2019"],"person":[{"family":"Man","given":"K. K. C.","display":"Man, K. K. C.","role":"aut","roleDisplay":"VerfasserIn"},{"family":"Banaschewski","given":"Tobias","role":"aut","roleDisplay":"VerfasserIn","display":"Banaschewski, Tobias"}],"id":{"eki":["1667308491"],"doi":["10.1038/tp.2016.216"]},"origin":[{"dateIssuedKey":"2016","dateIssuedDisp":"15 November 2016"}],"relHost":[{"title":[{"title":"Translational Psychiatry","title_sort":"Translational Psychiatry"}],"type":{"bibl":"periodical","media":"Online-Ressource"},"pubHistory":["1.2011 -"],"disp":"Methylphenidate and the risk of psychotic disorders and hallucinations in children and adolescents in a large health systemTranslational Psychiatry","physDesc":[{"extent":"Online-Ressource"}],"recId":"660807378","language":["eng"],"note":["Gesehen am 17.05.11"],"id":{"zdb":["2609311-X"],"eki":["660807378"],"issn":["2158-3188"]},"origin":[{"dateIssuedKey":"2011","publisher":"Nature Publishing Group","publisherPlace":"London","dateIssuedDisp":"2011-"}],"part":{"text":"6(2016,11) Artikel-Nummer e956, 7 Seiten","issue":"11","volume":"6","year":"2016","extent":"7"}}]} 
SRT |a MANKKCBANAMETHYLPHEN1520